Remus Pharmaceuticals Limited, a active public limited company, was established on 21 September 2015 in Ahmedabad, Gujarat, India. Engaging in wholesale within the trade sector, it holds CIN: U24232GJ2015PLC084536. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹12.50 Cr and a paid-up capital of ₹11.78 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹46.60 Cr and a net worth of ₹19.14 Cr. Employing 34 professional, Its leadership includes Swapnil Jatinbhai Shah (Director), Anar Swapnil Shah (Director), Roma Vinodbhai Shah (Whole-Time Director). Past directors included Swapnil Jatinbhai Shah, Anar Swapnil Shah, Roma Vinodbhai Shah. It holds ₹15.16 Cr open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 20 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1101 To 1103, South Tower,One 42,B/H Ashok Vatika, Nr.Jayantilal Park Brts, Ambli Bopal Roa, D, Ahmedabad, Gujarat, 380054.
L24232GJ2015PLC084536
084536
21 September 2015
₹12.50 Cr
₹11.78 Cr
Roc Ahmedabad
Listed
Active
Explore comprehensive insights into Remus Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapnil Jatinbhai Shah | Director | 21 Sep 2015 | Current |
| Anar Swapnil Shah | Director | 30 Dec 2020 | Current |
| Roma Vinodbhai Shah | Whole-Time Director | 21 Sep 2015 | Current |
| Vishrut Chandramauli Pathak | Director | 06 Jan 2023 | Current |
| Arpit Deepakkumar Shah | Managing Director | 21 Sep 2015 | Current |
| Balwant Purohit | Director | 06 Jan 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Feb 2023 | Past |
| Pramod Abcsdd | Director | 23 Feb 2023 | Past |
| Pramod Abcsdd | Director | 23 Feb 2023 | Past |
| Pramod Abcsdd | Additional Director | 28 Feb 2023 | Past |
| Pramod Abcsdd | Director | 23 Feb 2023 | Past |
| Pramod Abcsdd | Additional Director | 28 Feb 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Remus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹151,642,000.00
₹20,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2025 | Hdfc Bank Limited | ₹10.48 Cr | Open |
| 26 Jun 2025 | Hdfc Bank Limited | ₹2.19 Cr | Open |
| 02 Sep 2024 | Hdfc Bank Limited | ₹1.00 Cr | Open |
| 26 Feb 2024 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 29 Oct 2022 | Others | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Remus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Remus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 10.48 Cr with Charge ID 101185694 was registered on 26 Sep 2025. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.19 Cr with Charge ID 101117662 was registered on 26 Jun 2025. was documented.
Remus Pharmaceuticals Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100969089 was registered on 02 Sep 2024. was recorded as a recent event.
The activity Remus Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.50 Cr with Charge ID 100881296 was registered on 26 Feb 2024. was completed.
The CIN of Remus Pharmaceuticals Limited is L24232GJ2015PLC084536.
Remus Pharmaceuticals Limited is headquartered at 1101 To 1103, South Tower,One 42,B/H Ashok Vatika, Nr.Jayantilal Park Brts, Ambli Bopal Roa, D, Ahmedabad, Gujarat, 380054.
Remus Pharmaceuticals Limited was incorporated on 21 September 2015.
The current directors of Remus Pharmaceuticals Limited are
The primary industry of Remus Pharmaceuticals Limited is Trade.
Remus Pharmaceuticals Limited is listed.
The authorized capital of Remus Pharmaceuticals Limited is ₹12.50 Cr, and the paid-up capital is ₹11.78 Cr.
The compliance status of Remus Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX